ST-406

N/A

Report date: 2025/01/26 16:50:00

Base Information

Drug NameST-406
Drug Alias NameST406-mAbanti-ROR1 mAbs (Stromatis Pharma)ST-406
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionInactive tyrosine-protein kinase transmembrane receptor ROR1 antagonists
TargetsInactive tyrosine-protein kinase transmembrane receptor ROR1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesStromatis Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesStromatis Pharma Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A